Budapest, Hungary

Andras Selmezci

This inventor holds 1 USPTO granted patent. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andras Selmezci. Retrieved from https://idiyas.com/inventor/andras-selmezci

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andras Selmezci: Innovator in Gonadoliberine Analogues

Introduction

Andras Selmezci is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his work on gonadoliberine analogues. His innovative approach has led to advancements that may impact various medical applications.

Latest Patents

Andras Selmezci holds a patent for "Gonadoliberine analogues of high activity." This invention relates to novel gonadoliberine analogues of formula I, which are designed to exhibit enhanced biological activity. His work in this area showcases his commitment to developing effective therapeutic agents.

Career Highlights

Selmezci is associated with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company in Hungary. His role at the company has allowed him to focus on research and development, contributing to the advancement of medical science through his innovative ideas.

Collaborations

Throughout his career, Andras has collaborated with esteemed colleagues such as Janos Seprodi and Istvan Teplan. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceuticals.

Conclusion

Andras Selmezci's work in the development of gonadoliberine analogues highlights his innovative spirit and dedication to improving medical treatments. His contributions to the pharmaceutical industry are noteworthy and reflect his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…